Lanean...
Advances of target therapy on NOTCH1 signaling pathway in T-cell acute lymphoblastic leukemia
T-cell acute lymphoblastic leukemia (T-ALL) is one of the hematological malignancies. With the applications of chemotherapy regimens and allogeneic hematopoietic stem cell transplantation, the cure rate of T-ALL has been significantly improved. However, patients with relapsed and refractory T-ALL st...
Gorde:
| Argitaratua izan da: | Exp Hematol Oncol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7664086/ https://ncbi.nlm.nih.gov/pubmed/33292596 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-020-00187-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|